Table 2.
Selected centrally-determined Banff scores as a function of centrally-determined C4d positivity (≥10%).
| Central C4d Status | Central Banff i-score p=0.004 |
Total | Central Banff t-score p=0.026 |
Total | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Frequency/Row
Percent |
0 | 1 | 2 | 3 | 0 | 1 | 2 | 3 | ||
| Negative | 117 69% |
21 12% |
18 10% |
13 8% |
169 | 127 75% |
11 7% |
18 11% |
13 8% |
169 |
| Positive | 48 49% |
21 22% |
22 23% |
6 6% |
97 | 59 61% |
11 11% |
20 21% |
7 7% |
97 |
| Total | 165 | 42 | 40 | 19 | 266 | 186 | 22 | 38 | 20 | 266 |
| Central C4d Status | Central Banff ptc-score p<0.001 |
Total | Central Banff cg-score p=0.051 |
Total | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Frequency/Row
Percent |
0 | 1 | 2 | 3 | 0 | 1 | 2 | 3 | ||
| Negative | 90 53% |
55 33% |
11 7% |
13 8% |
169 | 121 72% |
14 8% |
12 7% |
22 13.02 |
169 |
| Positive | 28 29% |
44 45% |
18 19% |
7 7% |
97 | 58 60% |
12 12% |
8 8% |
19 20% |
97 |
| Total | 118 | 99 | 29 | 20 | 266 | 179 | 26 | 20 | 41 | 266 |
| Central C4d Status | Inflammation in Atrophic Regions P<0.001 |
Total | |||
|---|---|---|---|---|---|
|
Frequency/Row Percent |
0 | 1 | 2 | 3 | |
| Negative | 67 40% |
51 30% |
37 22% |
14 8% |
169 |
| Positive | 17 18% |
35 36% |
34 35% |
11 11% |
97 |
| Total | 84 | 86 | 71 | 25 | 266 |
*
P-values computed via the Wilcoxon Two-Sample test.